AZTA
Price
$48.90Alerts
Change
+$8.42 (+20.80%)
Updated
Nov 11 closing price
Capitalization
1.72B
91 days until earnings call
Intraday BUY SELL Signals
TNDM
Price
$18.77Alerts
Change
+$0.06 (+0.32%)
Updated
Nov 11 closing price
Capitalization
1.18B
105 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AZTA vs TNDM

AZTA vs TNDM Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AZTA vs. TNDM commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTA is a Buy and TNDM is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for AZTA with price predictions
Nov 10, 2026

AZTA in upward trend: price rose above 50-day moving average on October 19, 2026

AZTA moved above its 50-day moving average on October 19, 2026 date and that indicates a change from a downward trend to an upward trend. In 33 of 39 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on AZTA as a result. In 60 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.

The Moving Average Convergence Divergence (MACD) for AZTA just turned positive on November 09, 2026. Looking at past instances where AZTA's MACD turned positive, the stock continued to rise in 36 of 49 cases over the following month. The odds of a continued upward trend are 73%.

Following a +9.55% 3-day Advance, the price is estimated to grow further. Considering data from situations where AZTA advanced for three days, in 214 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.

The Aroon Indicator entered an Uptrend today. In 130 of 177 cases where AZTA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 73%.

Bearish Trend Analysis

The 10-day RSI Indicator for AZTA moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 26 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 87%.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AZTA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

AZTA broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.136) is normal, around the industry mean (4.964). P/E Ratio (-14.558) is within average values for comparable stocks, (40.591). Projected Growth (PEG Ratio) (0.310) is also within normal values, averaging (4.143). Dividend Yield (0.010) settles around the average of (0.005) among similar stocks. P/S Ratio (2.485) is also within normal values, averaging (56.876).

The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. AZTA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AZTA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for TNDM with price predictions
Nov 10, 2026

TNDM's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for TNDM turned positive on November 10, 2026. Looking at past instances where TNDM's MACD turned positive, the stock continued to rise in 35 of 42 cases over the following month. The odds of a continued upward trend are 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

TNDM moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for TNDM crossed bullishly above the 50-day moving average on October 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 15 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 83%.

Following a +10.64% 3-day Advance, the price is estimated to grow further. Considering data from situations where TNDM advanced for three days, in 210 of 266 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

The Aroon Indicator entered an Uptrend today. In 109 of 159 cases where TNDM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 69%.

Bearish Trend Analysis

The 10-day RSI Indicator for TNDM moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 28 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 48 of 53 cases where TNDM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.

The Momentum Indicator moved below the 0 level on November 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TNDM as a result. In 66 of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.

The 50-day moving average for TNDM moved below the 200-day moving average on October 13, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TNDM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

TNDM broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 8 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 36 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. TNDM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 89 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.024) is normal, around the industry mean (4.142). P/E Ratio (-18.789) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (9.850) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (1.150) is also within normal values, averaging (40.124).

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TNDM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
AZTA vs TNDM: Fundamental Ratings
AZTA
TNDM
OUTLOOK RATING
1..100
3234
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
89
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9398
PRICE GROWTH RATING
1..100
3546
P/E GROWTH RATING
1..100
9836
SEASONALITY SCORE
1..100
508

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AZTA's Valuation (13) in the Electronic Production Equipment industry is significantly better than the same rating for TNDM (89) in the Medical Specialties industry. This means that AZTA’s stock grew significantly faster than TNDM’s over the last 12 months.

AZTA's Profit vs Risk Rating (100) in the Electronic Production Equipment industry is in the same range as TNDM (100) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to TNDM’s over the last 12 months.

AZTA's SMR Rating (93) in the Electronic Production Equipment industry is in the same range as TNDM (98) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to TNDM’s over the last 12 months.

AZTA's Price Growth Rating (35) in the Electronic Production Equipment industry is in the same range as TNDM (46) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to TNDM’s over the last 12 months.

TNDM's P/E Growth Rating (36) in the Medical Specialties industry is somewhat better than the same rating for AZTA (98) in the Electronic Production Equipment industry. This means that TNDM’s stock grew somewhat faster than AZTA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZTATNDM
RSI
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 10 days ago
81%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
69%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (AZTA: $40.48 vs. TNDM: $18.71)
Brand notoriety: AZTA and TNDM are both not notable
AZTA represents the Pharmaceuticals: Other, while TNDM is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: AZTA: 62% vs. TNDM: 112%
Market capitalization -- AZTA: $1.72B vs. TNDM: $1.18B
AZTA [@Pharmaceuticals: Other] is valued at $1.72B. TNDM’s [@Medical/Nursing Services] market capitalization is $1.18B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $159.96B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.78B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTA’s FA Score shows that 1 FA rating(s) are green while TNDM’s FA Score has 0 green FA rating(s).

  • AZTA’s FA Score: 1 green, 4 red.
  • TNDM’s FA Score: 0 green, 5 red.
According to our system of comparison, both AZTA and TNDM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTA’s TA Score shows that 5 TA indicator(s) are bullish while TNDM’s TA Score has 5 bullish TA indicator(s).

  • AZTA’s TA Score: 5 bullish, 4 bearish.
  • TNDM’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, AZTA is a better buy in the short-term than TNDM.

Price Growth

AZTA (@Pharmaceuticals: Other) experienced а +8.99% price change this week, while TNDM (@Medical/Nursing Services) price change was +6.01% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.96%. For the same industry, the average monthly price growth was +6.35%, and the average quarterly price growth was +22.73%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.89%. For the same industry, the average monthly price growth was -4.69%, and the average quarterly price growth was -1.76%.

Reported Earning Dates

AZTA is expected to report earnings on Feb 10, 2027.

TNDM is expected to report earnings on Feb 24, 2027.

Industries' Descriptions

@Pharmaceuticals: Other (+1.96% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-2.89% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

AZTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZTA has been loosely correlated with IQV. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if AZTA jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZTA
1D Price
Change %
AZTA100%
-1.15%
IQV - AZTA
60%
Loosely correlated
-1.32%
RVTY - AZTA
59%
Loosely correlated
-1.01%
A - AZTA
59%
Loosely correlated
-1.27%
MTD - AZTA
59%
Loosely correlated
-0.62%
BRKR - AZTA
58%
Loosely correlated
-6.46%
More

TNDM and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNDM has been loosely correlated with GMED. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TNDM jumps, then GMED could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNDM
1D Price
Change %
TNDM100%
+2.97%
GMED - TNDM
45%
Loosely correlated
-1.49%
TFX - TNDM
45%
Loosely correlated
+0.37%
SHC - TNDM
40%
Loosely correlated
-1.03%
AZTA - TNDM
39%
Loosely correlated
-1.15%
A - TNDM
38%
Loosely correlated
-1.27%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EHTH0.460.01
+1.96%
eHealth
NOK8.250.07
+0.86%
Nokia Corp
UCB37.42-0.05
-0.13%
United Community Banks Inc
KPLT11.52-0.22
-1.87%
Katapult Holdings
TLSI2.85-0.37
-11.49%
TriSalus Life Sciences